MicroRNA-33a and let-7e inhibit human colorectal cancer progression by targeting ST8SIA1

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Colorectal cancer (CRC) is a leading cause of cancer mortality globally.
• Aberrant sialylation and dysregulation of microRNAs (miRNAs) are implicated in cancer progression.
• MicroRNA-33a (miR-33a) and Has-let-7e (let-7e) are non-coding RNAs with potential roles in cancer cell behavior.

Purpose of the Study:

• To investigate the role of miR-33a and let-7e in colorectal cancer progression.
• To explore the relationship between miR-33a/let-7e and ST8SIA1 in CRC.
• To evaluate the miR-33a/let-7e-ST8SIA1 axis as a potential therapeutic target for CRC.

Main Methods:

• Quantitative real-time PCR to measure miRNA and mRNA levels in CRC tissues and cell lines.
• Luciferase reporter assays to confirm direct binding of miRNAs to the ST8SIA1 3'-UTR.
• In vitro and in vivo experiments involving miRNA inhibition/ectopic expression and ST8SIA1 knockdown/restoration.

Main Results:

• miR-33a and let-7e were significantly downregulated in CRC samples and chemoresistant cells, inversely correlated with ST8SIA1 expression.
• miR-33a and let-7e directly target and inhibit ST8SIA1 expression.
• Downregulation of miR-33a/let-7e promoted CRC cell proliferation, invasion, angiogenesis, chemoresistance, and tumor growth by upregulating ST8SIA1.
• Ectopic expression of miR-33a/let-7e or knockdown of ST8SIA1 suppressed these aggressive phenotypes.

Conclusions:

• The miR-33a/let-7e-ST8SIA1 axis plays a critical role in colorectal cancer progression and chemoresistance.
• Altered expression of miR-33a/let-7e contributes to CRC by regulating ST8SIA1.
• Targeting the miR-33a/let-7e-ST8SIA1 pathway represents a promising therapeutic strategy for colorectal cancer.